Physician Assistant in Manchester, CT Accepting Medicare

68 Physician Assistant nurses found. Showing 61 - 68

Raymond Charles Kaiser, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 256 N Main St, Manchester, CT 06042 Phone: 860-646-8595    Fax: 860-645-3216

Chad Bandosz, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 71 Haynes St, Manchester, CT 06040 Phone: 860-646-1222

Michael Anthony Ascenzia, P.A.-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 360 Tolland Tpke Ste 1a, Manchester, CT 06042 Phone: 860-553-6551

Kevin Andrew Belanger, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 277 Middle Tpke W, Manchester, CT 06040 Phone: 860-432-4640

Maureen Robert, P.A.-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 27 Hilliard St, Manchester, CT 06042 Phone: 860-646-3903    Fax: 860-645-3492

Mr. Thomas Russell Rozea, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 71 Haynes St, Manchester, CT 06040 Phone: 860-533-3414

Colleen Booth, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 71 Haynes St, Manchester, CT 06040 Phone: 860-646-1222

Irm Khan, P.A. Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 353 Main St, Manchester, CT 06040 Phone: 860-649-3477

News Archive

New biomarker for pancreatic cancer effectively targets potential therapy for small survival rate

University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.

Study investigates molecular markers in drug-resistant ovarian cancer

A new study by TCD researchers investigates drug-resistant ovarian cancer cells. The findings which have been recently published in the international publication, PLoS One will increase understanding of molecular markers in drug-resistant ovarian cancer with a view to improving clinical treatment.

Game changing, breakthrough early cancer detection technology presented at ASCO 2015

Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer and Scientist Dr. Chris Yu and the Anpac research team are introducing what the 2015 Nobel Prize Laureate Summit on Biomedical Science (NPLS) organizers published as, "game changing" and "breakthrough" early cancer detection technology research results at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, May 29 – June 2, 2015.

Romney says loss the result of Obama's 'gifts' to minority voters, women and young people

Certain provisions of the 2010 health law were the key "gifts" GOP presidential hopeful Mitt Romney said were to blame for his loss. Other Republican leaders, including Louisiana Gov. Bobby Jindal fiercely rebuffed Romney's comments.

MGH Bipolar CHOICE trial to evaluate effectiveness of new medications compared to lithium

The Massachusetts General Hospital (MGH) Bipolar Clinic and Research Program with the Bipolar Trials Network is launching Bipolar CHOICE, a 10-site nationwide trial evaluating the real-world advantages and disadvantages of quetiapine, a widely prescribed second generation antipsychotic mood stabilizing medication, compared to lithium, the gold standard mood stabilizer, for the treatment of outpatients with bipolar disorder.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3
• 4(current)